Abstract

Dexrazoxane 1-mg/mL Injection

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2013 - Volume 17, Number 2

Page(s): 149

Download in electronic PDF format for $75
  • Dexrazoxane 1-mg/mL Injection Page 1

Abstract

A formulation for preparing Dexrazoxane 1-mg/mL Injection. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • dexrazoxane
  • formulation
  • cardioprotectant
  • cancer chemotherapy
  • heart protection
  • toxic effect

Related Categories

  • CANCER AND AIDS
  • FORMULATIONS
  • STERILE PREPARATIONS
  • CARDIOLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2013
Pg. 149
Dexrazoxane 1-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
Mar/Apr 2004
Pg. 126-129
Basics of Compounding for the Treatment of Warts
Author(s): Allen Loyd V Jr
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
Mar/Apr 2012
Pg. 117-124
Gastrointestinal Mucositis: Focus on the Treatment of the Effects of Chemotherapy and Radiotherapy on the Rectum
Author(s): Zur Eyal
May/Jun 1997
Pg. 175
Antiemetic Injection for Cancer Chemotherapy
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 129-134
View Sample
Basics of Compounding for Terrorist Attacks, Part 2
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 333
Metoprolol Tartrate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2013
Pg. 66
Granisetron 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2015
Pg. 62
Cisplatin 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 18-23
Reversing Erectile Dysfunction and Urinary Incontinence After Prostatectomy or Radiotherapy: The Stanley Prostate-Cancer Treatment Protocol
Author(s): McKettrick Greg, Yoch Doug
Jan/Feb 2012
Pg. 79
Zinc 1-mg/mL and 5-mg/mL Injections
Author(s): Allen Loyd V Jr
Nov/Dec 2002
Pg. 455
Methadone HCl 1-mg/mL, 2-mg/mL, and 5-mg/mL Injection
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 132-134
Stability of Aminocaproic Acid Injection Admixtures in 5% Dextrose Injection and 0.9% Sodium Chloride Injection
Author(s): Zhang Yan-ping, Trissel Lawrence A
Sep/Oct 2001
Pg. 401-405
Release of Morphine Sulfate from Compounded Slow-Release Capsules: The Effect of Formulation on Release
Author(s): Bogner Robin H, Szwejkowski Jessica, Houston Alana
Nov/Dec 2004
Pg. 458-460
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
Author(s): McElhiney Linda F
Mar/Apr 2010
Pg. 108-111
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Author(s): Bramwell Bethany L
Jul/Aug 2015
Pg. 328
Cytarabine 50-mg/mL Injection
Author(s): Allen Loyd V
Nov/Dec 2022
Pg. 516-521
Formulation Development of Modafinil Sprinkle Dosage Form: Study on the Effect of Food on Dosage
Author(s): Kumaravelrajan Rajagopal, Karthik B, Venkatasan Suba
Nov/Dec 2006
Pg. 457
Hydralazine Hydrochloride 1-mg/mL or 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr